Serinus Biosciences
New York, NY
Serinus Biosciences develops technologies to understand how chemicals work inside malignant tumor cells. They are developing a new generation of AI for drug development by leveraging knowledge-primed models and cancer biology. Their technique makes it possible to create medicines that are effective for a variety of patient groups, bypass resistance mechanisms, and support combinations by design. Serinus Biosciences is headquartered in New York City, New York and was founded in 2022.
serinus.bioCompany Details
Founded
- 2022
Employees
- Between 2 - 10 employees
Raised
- $650,000
Headquarters Location
- New York, NY
Public
- No
Acquired
- No
CEO
Adam Yaari
Founders
- Adam YaariMaxwell Sherman
Company Collections
These are collections Serinus Biosciences is a part of. Click on the collection name to view similar companies.
Serinus Biosciences' Investors
Serinus Biosciences' Industries
Serinus Biosciences' Tech Stack
Serinus Biosciences Headquarters Location
Total Amount Raised: $650,000
Serinus Biosciences' Investors
Serinus Biosciences Funding Rounds
Series Unknown
$150,000
Series Unknown Investors
Merck Digital Sciences StudioPre Seed
$500,000
Pre Seed Investors
Y Combinator
Serinus Biosciences Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Serinus Biosciences.